Mechanistic description
Develop therapeutic chaperones or enhance endogenous chaperone systems (HSP70, HSP90) to prevent or reverse C112R-induced conformational changes and maintain proper APOE4 folding
Debate provenance: derived from debate sess_sda-2026-04-01-gap-010 on question: APOE4 differs from APOE3 by C112R causing domain interaction that alters lipid binding and amyloid clearance.. Consensus signal: domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms APOE, APOE4, C112R, Chaperone-Mediated, HSP70, HSP90, Refolding. Novelty signal: skeptic-discussed-with-qualified-concession.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Chaperone-Mediated APOE4 Refolding Therapy. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-083bf9f93d21
@misc{scidex_hypothesis_hdebate0,
title = {Chaperone-Mediated APOE4 Refolding Therapy},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-083bf9f93d21},
note = {SciDEX artifact hypothesis:h-debate-083bf9f93d21}
}